Adaptrin is a botanical formula that was developed by five successive generations of physicians of the Badmaev family. It is formulated according to the principles of Tibetan medicine. The formula was introduced to Switzerland (via Russia and Poland) in the 1960's. Since then, the compound has been subjected to extensive clinical testing. Over the past 25 years, about 30 scientific studies have been conducted, making it the most extensively researched botanical combination formula. Furthermore, the product has been registered in Switzerland for treatment of poor circulation due to atherosclerosis, in particular for peripheral vascular disease.
|
